These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 26038094)

  • 21. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction.
    Oh D; Chong J; Song TJ; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2083-2090. PubMed ID: 35869749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients.
    Sakai Y; Iwai T; Shimura K; Gon K; Koizumi K; Ijima M; Chiba K; Nakatani S; Sugiyama H; Tsuyuguchi T; Kamisawa T; Maetani I; Kida M
    World J Gastroenterol; 2018 Jan; 24(1):69-75. PubMed ID: 29358883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic stenting for inoperable malignant biliary obstruction: A systematic review and meta-analysis.
    Zorrón Pu L; de Moura EG; Bernardo WM; Baracat FI; Mendonça EQ; Kondo A; Luz GO; Furuya Júnior CK; Artifon EL
    World J Gastroenterol; 2015 Dec; 21(47):13374-85. PubMed ID: 26715823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial.
    Mukai T; Yasuda I; Nakashima M; Doi S; Iwashita T; Iwata K; Kato T; Tomita E; Moriwaki H
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):214-22. PubMed ID: 22415652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage of hilar cholangiocarcinoma predicts recurrence of biliary obstruction in patients with metal stents.
    Siddiqui A; Shahid H; Sarkar A; Cox K; Kowalski TE; Loren DE; Sharma A; Laing P; Birch M; Adler DG
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1169-73. PubMed ID: 23811239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture.
    Miura S; Kanno A; Masamune A; Hamada S; Hongou S; Yoshida N; Nakano E; Takikawa T; Kume K; Kikuta K; Hirota M; Yoshida H; Katayose Y; Unno M; Shimosegawa T
    Endoscopy; 2016 Jun; 48(6):536-45. PubMed ID: 26987646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.
    Tarar ZI; Farooq U; Gandhi M; Ghous G; Saleem S; Kamal F; Imam Z; Jamil L
    Eur J Gastroenterol Hepatol; 2023 Jun; 35(6):646-653. PubMed ID: 37129575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-stent radiofrequency ablation with uncovered metal stent placement for tumor ingrowth/overgrowth causing self-expandable metal stent occlusion in distal malignant biliary obstruction: multicenter propensity score-matched study.
    Park N; Jung MK; Kim EJ; Paik WH; Cho JH
    Gastrointest Endosc; 2023 Apr; 97(4):694-703.e2. PubMed ID: 36460085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant endobiliary radio-frequency ablation combined with self-expandable biliary metal stents for unresectable malignant hilar strictures: A pragmatic comparative study.
    Jagtap N; Kumar CS; Lakhtakia S; Ramchandani M; Memon SF; Asif S; Kalapala R; Nabi Z; Basha J; Gupta R; Tandan M; Reddy DN
    Indian J Gastroenterol; 2024 Sep; ():. PubMed ID: 39240508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reintervention for occluded metal stent in malignant bile duct obstruction: A prospective randomized trial comparing covered and uncovered metal stent.
    Lee BS; Ryu JK; Jang DK; Chung KH; Yoon WJ; Kim J; Woo SM; Lee SH; Lee WJ; Kim YT
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1901-1907. PubMed ID: 27029890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study.
    Laleman W; van der Merwe S; Verbeke L; Vanbeckevoort D; Aerts R; Prenen H; Van Cutsem E; Verslype C
    Endoscopy; 2017 Oct; 49(10):977-982. PubMed ID: 28732391
    [No Abstract]   [Full Text] [Related]  

  • 32. Nitinol versus steel partially covered self-expandable metal stent for malignant distal biliary obstruction: a randomized trial.
    Soderlund C; Linder S; Bergenzaun PE; Grape T; Hakansson HO; Kilander A; Lindell G; Ljungman M; Ohlin B; Nielsen J; Rudberg C; Stotzer PO; Svartholm E; Toth E; Frozanpor F
    Endoscopy; 2014 Nov; 46(11):941-8. PubMed ID: 25321620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of occluded metallic stents in malignant hilar biliary stricture.
    Fujii M; Kawamoto H; Tsutsumi K; Kato H; Hirao K; Kurihara N; Mizuno O; Ishida E; Ogawa T; Fukatsu H; Yamamoto K
    Hepatogastroenterology; 2013 May; 60(123):447-51. PubMed ID: 23108079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis.
    Ma KW; Chan ACY; She WH; Chok KSH; Dai WC; Tsang S; Cheung TT; Lo CM
    Surg Endosc; 2018 Feb; 32(2):971-976. PubMed ID: 28779260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.
    Jarosova J; Zarivnijova L; Cibulkova I; Mares J; Macinga P; Hujova A; Falt P; Urban O; Hajer J; Spicak J; Hucl T
    Gut; 2023 Nov; 72(12):2286-2293. PubMed ID: 37652677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic sphincterotomy associated cholangitis in patients receiving proximal biliary self-expanding metal stents.
    Zhou H; Li L; Zhu F; Luo SZ; Cai XB; Wan XJ
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):643-9. PubMed ID: 23232637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic Biliary Stenting Versus Percutaneous Transhepatic Biliary Stenting in Advanced Malignant Biliary Obstruction: Cost-effectiveness Analysis.
    Sun XR; Tang CW; Lu WM; Xu YQ; Feng WM; Bao Y; Zheng YY
    Hepatogastroenterology; 2014 May; 61(131):563-6. PubMed ID: 26176036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: A pilot multicenter randomized comparative trial.
    Kang H; Han SY; Cho JH; Kim EJ; Kim DU; Yang JK; Jeon S; Park G; Lee TH
    J Hepatobiliary Pancreat Sci; 2022 Apr; 29(4):469-478. PubMed ID: 34800357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic Ultrasound-Guided Antegrade Radiofrequency Ablation and Metal Stenting With Hepaticoenterostomy for Malignant Biliary Obstruction: A Prospective Preliminary Study.
    Inoue T; Ibusuki M; Kitano R; Kobayashi Y; Ohashi T; Sumida Y; Nakade Y; Ito K; Yoneda M
    Clin Transl Gastroenterol; 2020 Oct; 11(10):e00250. PubMed ID: 33108126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of high risk factors for endoscopic retrograde cholangiopancreatography biliary metallic stenting after malignant duodenal stricture SEMS implantation.
    Yao JF; Zhang L; Wu H
    J Biol Regul Homeost Agents; 2016; 30(3):743-748. PubMed ID: 27655491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.